x

Growing companies with advanced AI

SAIGroup is a private investment firm investing in businesses with the potential to become leaders in enterprise AI solutions. SAI Group’s investments enable our portfolio companies to accelerate their innovation and growth. Principal owner and investor Dr. Romesh Wadhwani has made a commitment to invest up to $ 1 billion in SAIGroup.

Contact Us
Investment Focus

Investments in enterprise software companies

Control and minority investments in companies that have commercialized, high-value AI solutions with rapid deployment, innovative technology, and a referenceable customer base

Learn More
Unique Approach

Blending agility, flexibility, and expertise to catalyze value

SAIGroup provides the capital and deep business expertise essential for growth. Proven operational strategies couple with deep vertical and horizontal domain experience to drive growth through innovation, technology, talent, and go-to-market functions.

See our approach
Leading Portfolio

Building leaders in enterprise AI software

In five years, SAIGroup has become one of the largest, fastest-growing players in enterprise AI by building two leading businesses, SymphonyAI and ConcertAI. Together, these companies are approaching $500 million in revenue in 2022, growing ARR over 30% annually, and employing nearly 3,000 people worldwide.

view portfolio

Founder, Chairman, and CEO Romesh Wadhwani on SAIGroup’s Mission

Watch Video

SAIGroup

The SAIGroup portfolio is comprised of two rapidly growing enterprise AI software companies serving the needs of several key verticals. We seek acquisitions and control investments for these two operating businesses and at the SAIGroup level.

View Portfolio

SymphonyAI

The leader in enterprise AI for key vertical sectors

SymphonyAI is building the leading enterprise AI company for digital transformation across the most important and resilient growth verticals, including retail, CPG, financial services, manufacturing, media, and IT operations, with over 1,000 leading enterprises as clients. Since its founding in 2017, SymphonyAI has grown rapidly to nearly 2,000 talented leaders, data scientists, and other professionals.

Learn more about SymphonyAI
CPG
Financial Services
Industrial Manufacturing
IT Operations
Media
Public Sector
Retail

SymphonyAI Retail CPG

Understand your consumers. Advise and collaborate with retailers. Outpace your competition. Promote your brand and build loyalty through AI-empowered insights that drive growth and create wins for consumers, retailers, and CPG companies.

Visit

SymphonyAI Sensa

Stop Financial Crime. Optimize Liquidity. Prevent Fraud. Drive revenue and grow profitability with innovative enterprise AI solutions delivering holistic insights for banks and financial institutions.

Visit

Symphony IndustrialAI

Operate at full potential. Optimize manufacturing performance with breakthrough enterprise AI SaaS solutions for industrial manufacturing profit growth and safety.

Visit

Symphony SummitAI

Automate processes. Accelerate resolutions. Transform employee experiences with breakthrough enterprise AI SaaS solutions that eliminate steps and optimize workflows for IT service providers.

Visit

SymphonyAI Media

Improve forecasting. Reduce churn. Monetize content. Grow top-line revenue with AI SaaS solutions for data analysis and predictive insights.

Visit

SymphonyAI Public Sector

Reduce costs. Control waste. Deliver transformative mission-relevant advances with predictive analytics and breakthrough AI solutions delivering value across intelligence, defense, healthcare, and research communities.

Visit

SymphonyAI Retail CPG

Understand your customer. Create satisfying shopping experiences. Deliver on plans and promises. Empower the retail enterprise to meet and exceed customer needs and financial goals from consumer science to the shelf.

Visit

ConcertAI

The leader in real world data and enterprise AI for life sciences and healthcare

ConcertAI is accelerating clinical drug development, improving image interpretation and clinical decision-making, and improving patient outcomes using advanced AI platforms and real world data from over 4 million patients. ConcertAI’s clients include 35 of the world’s top life sciences companies and more than 1,300 hospital systems globally. Since its founding in 2017, ConcertAI has grown rapidly to over 900 talented leaders, data scientists, and other professionals.

Learn more about ConcertAI
Data Products
Predictive Patient
Commercial Solutions
STAR
Custom Expertise Services

Real-World Data for Precision Evidence

ConcertAI’s rich suite of independent real-world data products are fit-for-purpose to meet a variety of research and real-world evidence uses cases across the enterprise.

Visit

Improve Therapy Initiation and Adherence

Predictive Patient transforms millions of health and behavioral records, and applies advanced AI models to improve the patient experience from therapy initiation through adherence.

Visit

Innovative Technology and Quality Data Management for Trusted, Actionable Patient Insights

Maximize the complete therapy experience with visibility into hurdles that inhibit how quickly patients get the medicines they need as well as the issues causing patients to discontinue therapy. Trust in the value unlocked from bringing together diverse 1st and 3rd party data sources. Insights are consumable, clear, and actionable

Visit

Enterprise, HIPAA-Compliant Solution for Actionable Patient Insights

Advanced AI algorithms and powerful data visualizations allow unique visibility into patient journey and adherence trends for optimized patient experiences and maximized brand value.

Visit

Custom Data and Research

Work with our team of Real-World Evidence scientists and their extensive knowledge of Real-World Data and data science in Life Sciences. Ask nuanced questions, explore results, and design innovative studies.

Visit
CPG
Financial Services
Industrial Manufacturing
IT Operations
Media
Public Sector
Retail

SymphonyAI Retail CPG

Understand your consumers. Advise and collaborate with retailers. Outpace your competition. Promote your brand and build loyalty through AI-empowered insights that drive growth and create wins for consumers, retailers, and CPG companies.

Visit

SymphonyAI Sensa

Stop Financial Crime. Optimize Liquidity. Prevent Fraud. Drive revenue and grow profitability with innovative enterprise AI solutions delivering holistic insights for banks and financial institutions.

Visit

Symphony IndustrialAI

Operate at full potential. Optimize manufacturing performance with breakthrough enterprise AI SaaS solutions for industrial manufacturing profit growth and safety.

Visit

Symphony SummitAI

Automate processes. Accelerate resolutions. Transform employee experiences with breakthrough enterprise AI SaaS solutions that eliminate steps and optimize workflows for IT service providers.

Visit

SymphonyAI Media

Improve forecasting. Reduce churn. Monetize content. Grow top-line revenue with AI SaaS solutions for data analysis and predictive insights.

Visit

SymphonyAI Public Sector

Reduce costs. Control waste. Deliver transformative mission-relevant advances with predictive analytics and breakthrough AI solutions delivering value across intelligence, defense, healthcare, and research communities.

Visit

SymphonyAI Retail CPG

Understand your customer. Create satisfying shopping experiences. Deliver on plans and promises. Empower the retail enterprise to meet and exceed customer needs and financial goals from consumer science to the shelf.

Visit
Data Products
Predictive Patient
Commercial Solutions
STAR
Custom Expertise Services

Real-World Data for Precision Evidence

ConcertAI’s rich suite of independent real-world data products are fit-for-purpose to meet a variety of research and real-world evidence uses cases across the enterprise.

Visit

Improve Therapy Initiation and Adherence

Predictive Patient transforms millions of health and behavioral records, and applies advanced AI models to improve the patient experience from therapy initiation through adherence.

Visit

Innovative Technology and Quality Data Management for Trusted, Actionable Patient Insights

Maximize the complete therapy experience with visibility into hurdles that inhibit how quickly patients get the medicines they need as well as the issues causing patients to discontinue therapy. Trust in the value unlocked from bringing together diverse 1st and 3rd party data sources. Insights are consumable, clear, and actionable

Visit

Enterprise, HIPAA-Compliant Solution for Actionable Patient Insights

Advanced AI algorithms and powerful data visualizations allow unique visibility into patient journey and adherence trends for optimized patient experiences and maximized brand value.

Visit

Custom Data and Research

Work with our team of Real-World Evidence scientists and their extensive knowledge of Real-World Data and data science in Life Sciences. Ask nuanced questions, explore results, and design innovative studies.

Visit

Our Culture, Values and Approach

SAIGroup and its portfolio companies share four key common values.
CUSTOMER CENTRIC

Deliver the highest value in months, not years

GROWTH THROUGH INNOVATION

Invest in new breakthrough products and solutions

FOCUS ON TALENT

Attract and retain the best talent

HIGH PERFORMANCE CULTURE

Emphasis on urgency, teamwork, results

Expert Team

Transforming companies with deep vertical expertise

Chris Hasslinger

Senior Investment Partner

Read Bio

Chris Hasslinger is a senior investment partner at SAIGroup with over 25 years of deal-making experience across the healthcare and software industries. He is responsible for leading acquisition, investment, and partnership activity at SAIGroup.

Throughout his career, Chris has led a wide range of strategic transactions and value-enhancing partnerships, driving several billions of aggregate acquisition value. Most recently, Chris was senior vice president at OptumInsight, responsible for acquisition strategy and execution and partnerships for the critical healthcare technology and analytics business of UnitedHealth Group. Previously, Chris led acquisitions within Optum’s corporate development group, focusing on technology and related healthcare solutions.

Before Optum, Chris focused on growth companies in enterprise software for nearly two decades in investment banking, spending most of his banking career at Piper Jaffray, where he led the software practice. His banking experience includes buy and sell-side M&A and equity and debt financing in public and private markets for growth companies across a wide range of software sectors.

Chris has a bachelor’s of science degree from the Carlson School of Management at the University of Minnesota.

Dr. Romesh Wadhwani

Founder, Chairman, and CEO

Read Bio

Dr. Romesh Wadhwani is the founder, chairman, and CEO of SAIGroup, a fast-growing operating group of leading AI companies that deliver a new generation of advanced AI solutions to transform the enterprise. SAIGroup companies focus on driving revenue growth and operational excellence for customers in their vertical sectors, including retail, CPG, life sciences, payer/provider, manufacturing and process industries, defense, financial services, and media.

Prior to founding SAIGroup, Dr. Wadhwani was the founder and CEO of Symphony Technology, a strategic private equity firm that builds great software and technology-enabled services companies. Dr. Wadhwani founded STG in 2002, growing it from startup to $ 2.5 billion in combined revenue and 15,000 employees. Dr. Wadhwani was the founder and CEO of Aspect Development Inc., a B2B software firm. Aspect Development was acquired in 2000 for $9.3 billion, the largest software acquisition at the time.

Dr. Wadhwani established the Wadhwani Foundation in 2001 to accelerate job creation and economic development in India and other emerging economies through large scale initiatives in entrepreneurship, innovation, and skilling. Today, the Wadhwani Foundation is active in India and more than 20 countries across Asia, Africa, and Latin America.

Wadhwani Advantage, Wadhwani Entrepreneur, and Wadhwani Innovate are three large initiatives for helping hundreds of entrepreneurs start new businesses and grow existing SME businesses each year, creating a large number of new jobs. The Wadhwani Advantage initiative allows tens of thousands of students each year learn employability and soft skills and get placed in high-quality jobs.

Dr. Wadhwani and his brother Sunil Wadhwani have established the Wadhwani Institute for AI for Social Good in Mumbai, a research institute and global hub for developing AI solutions for social good in public health, education, skilling, job creation, and infrastructure. Indian Prime Minister Modi inaugurated WIAI in 2018. The institute was awarded the Google Prize in 2019 for one of its innovative initiatives.

In January 2020, the Government of India awarded Dr. Wadhwani the Padma Shri honor, the fourth-highest civilian award in the Republic of India. President Barack Obama appointed Dr. Wadhwani to the board of trustees for the John F. Kennedy Center. Dr. Wadhwani is a board member of the Center for Strategic and International Studies in Washington, DC and is a member of the Gates Buffet Giving Pledge.

Dr. Wadhwani holds a bachelor of science degree in electrical engineering from the Indian Institute of Technology Bombay and a master’s of science and Ph.D. in electrical engineering from Carnegie Mellon University. Dr. Wadhwani received an honorary doctorate from the Indian Institute of Technology Bombay in August 2018.

Pradyut Shah

Senior Investment Partner

Read Bio

Pradyut Shah is a senior investment partner at SAIGroup and oversees all investment and acquisition activity at the firm. He currently serves as a Director on the Boards of Symphony IndustrialAI, SymphonyAI Media and TeraRecon.

Pradyut was previously a Managing Director and founding member of Insignia Capital Group, a middle-market private equity firm where he served as a Director on the Boards of portfolio companies in the consumer sector. Prior to Insignia, he was a Vice President at Behrman Capital where he was significantly involved with a number of private equity investments from 2004 to 2011, including Athena Diagnostics, Brooks Equipment Company, Peacock Engineering Company, Pelican Products and WIL Research Laboratories. Prior to Behrman, Pradyut spent 3 years at Credit Suisse First Boston’s Technology Group.

He attended the Jerome Fisher Program in Management & Technology at the University of Pennsylvania, where he graduated summa cum laude with a B.S.E. in Computer Science from the School of Engineering and Applied Science and a B.S. in Economics with a major in Finance from the Wharton School of Business.

Eshwar Belani

Operating Partner

Read Bio

Eshwar is a partner at SAIGroup focused on incubating, transforming, and growing companies that leverage AI to disrupt B2B markets. Eshwar assumes interim operating roles across SAIGroup’s portfolio to accelerate company business goals and enhance customer and shareholder value. Prior to SAIGroup, Eshwar led products and alliances for Rubrik, where he launched a suite of products that grew the company to an annual run rate of $100 million after only six quarters. Rubrik is the fastest-growing enterprise infrastructure company and was featured on Forbes’ 2018 The Cloud 100 list.

Previously, Eshwar was the vice president of strategy at Rocket Fuel (NASDAQ:FUEL), responsible for shaping strategic direction and driving ancillary revenue through new business initiatives. He helped close Rocket Fuel’s $230M acquisition of [x+1] to expand Rocket Fuel’s enterprise solutions portfolio. Prior, Eshwar was Rocket Fuel’s vice president of products and business development, responsible for brand and direct response products and data and measurement partnerships. Eshwar helped Rocket Fuel grow revenue to over $240 million to claim the #1 spot in Deloitte’s Technology Fast 500™ list.

Previously, Eshwar was the founder and CEO of Sensact Applications, an IoT company focused on solutions for smart physical environments; drove product strategy for Epiphany’s (now Infor) marketing and analytics products, including Epiphany’s flagship CRM marketing and analytics platforms; co-founder and CTO of iLeverage (acquired by Epiphany in 2000), an advertising and collaborative selling solutions company; and a software development engineer in Oracle’s Application Server Group.

Eshwar serves as an advisor at Singularity University and Alchemist Accelerator and is a charter member of TiE Silicon Valley. He holds a MS in computer science from U.C. Berkeley, Management of Technology from U.C. Berkeley, and a B.Tech in computer science from the Indian Institute of Technology (IIT), Madras. He has authored several academic publications and holds six patents.

Erica Schroeder

Head of Marketing

Read Bio

Erica leads SAIGroup marketing, working with SAIGroup portfolio companies to build awareness and create marketing programs that drive enterprise AI adoption across vertical industries.

Prior to joining SAI Group, Erica was senior director of marketing for C3.ai, where she led content and drove a number of other marketing functions, partnering closely with product and sales organizations. Prior to C3.ai, Erica was senior director of marketing for SunPower Corp., where she led marketing for SunPower’s commercial and utility solar businesses across the U.S, Europe, and Japan. Prior to SunPower, Erica was a director of marketing at Cisco Systems Inc., leading marketing for a variety of emerging technology products. She also held leadership corporate communications and analyst and public relations positions in Cisco’s service provider business.

Erica began her career as a journalist at PC Week (now eWeek), where she edited several news sections, wrote a column, spoke at industry events, and covered a variety of markets, including telecommunications, networking, enterprise software, storage, and enterprise video.

Erica holds a bachelor’s degree from Duke University and has completed executive MBA programs at Kellogg School of Management and Oxford University’s Said Business School.

Jimmy Sourbeer

Vice President, Investment Team

Read Bio

Jimmy Sourbeer is a vice president on the SAIGroup investment team. His responsibilities include sourcing, evaluating, and executing acquisitions. Jimmy was previously a vice president at Resurgens Technology Partners, a lower middle-market private equity firm focused on software and tech-enabled services businesses. Prior to Resurgens, Jimmy was a vice president at PGi, where he assisted in leading the execution of strategic investments, deploying over $175 million in four acquisitions. Prior to PGi, Jimmy was an associate at ICG, where he was involved in identifying and investing in software businesses. He began his career in investment banking.

Jimmy holds a bachelor’s of arts degree in economics from Northwestern University and an MBA from Columbia Business School, where he was a member of the Private Equity Fellows program, received the Robert H. Montgomery Prize in accounting, and graduated with Dean’s Honors.

Jimmy is based in Los Altos, CA, and can be reached at Jsourbeer@symphonyai.com

Jason Williams

Vice President, Investment Team

Read Bio

Jason Williams is a senior associate for SAIGroup, focused on executing acquisitions across several verticals. Prior to joining SAIGroup in 2018, Jason worked as an investment professional at Golden Gate Capital and at The Gores Group, where he focused on investments in the industrial and technology sectors. Previously, he worked as a consultant in the Dallas office of the Boston Consulting Group, where he conducted numerous projects in the technology media and telecom industries.

Jason has a bachelor degree in neurobiology with a secondary degree in economics from Harvard College.

Michael Cashin

Head of Business Development

Read Bio

Mike is a director and head of business development for SAIGroup. He is responsible for all aspects of deal origination and qualification. Before joining SAIGroup, Mike was the head of corporate development for ESW Capital, a $2 billion private investment firm focused on enterprise software acquisitions.

Previously, Mike was a member of the business development team and led the technology efforts at OpenGate Capital. Mike began his career in private equity as an associate with Pegasus Capital Group.

Mike holds an MBA with a focus in finance and entrepreneurial management from Pepperdine Graziadio Business School and a bachelor’s of science degree in business administration from Pepperdine University.

Mike is based in Los Angeles and can be reached at mcashin@symphonyai.com.

Nick Balay

Senior Investment Associate

Read Bio

Nick Balay is a senior investment associate at SAIGroup, responsible for sourcing, evaluating, and executing acquisitions across healthcare and other vertical sectors.

Prior to joining SAIGroup in 2022, Nick was a project leader in the Minneapolis office of the Boston Consulting Group, where he served healthcare, public sector, industrial goods, and private equity clients on various topics, including strategy, data & analytics, organization design, and buy-side due diligence. Previously, he worked in corporate development at Optum/UnitedHealth Group where he evaluated and executed M&A transactions in healthcare information technology, services, and delivery.

Nick earned his MBA with high honors from the University of Chicago Booth School of Business. He also holds a bachelor’s degree in economics from the University of Chicago with a minor in Near Eastern languages and civilizations.

Malik Gill

Investment Associate

Read Bio

Malik is an associate on the SAIGroup investment team, focused on evaluating and executing acquisitions. Prior to joining SAIGroup in 2021, Malik was an investment banking associate at GCA Advisors where he worked on M&A transactions in the software, advertising technology, financial technology, and tech-enabled services sectors. Previously, Malik worked at Beacon Tree Capital LLC as an analyst and Cisco Systems Inc. in corporate development.

Malik holds a bachelor’s degree in economics from Harvard College.

Senjie Wang

Investment Associate

Read Bio

Senjie is an associate on the SAIGroup investment team, responsible for evaluating and executing acquisitions. Prior to joining SAIGroup, Senjie was an investment banking analyst at Needham & Company, where he worked on M&A transactions in the software, internet, digital media, and consumer technology sectors. Previously, Senjie worked at Macquarie Capital as an investment banking analyst.

Senjie holds a bachelor’s degree in economics and statistics from the University of California, Berkeley.

Anusha Sriram

Senior Investment Analyst

Read Bio

Anusha is an analyst on the SAIGroup investment team, responsible for evaluating new market opportunities across a variety of established and emerging technologies and industries. She brings her talents to successful acquisition and investment sourcing, diligence, and close.

Prior to joining SAIGroup, Anusha was responsible for legal and policy research for the Equals Center for Promotion of Social Justice, focusing on advocacy and research projects for the rights of persons with disabilities in India. She was previously a caseworker at the Trinity Centre Cardiff Asylum Support Advocacy group, working on pro bono cases to help asylum seekers in the UK fight for necessities such as access to housing. Anusha has lived and worked in the United States, United Kingdom, Paris, and India.

Anusha holds a bachelor of law degree in law from Cardiff University.